Literature DB >> 9802307

Fat accumulation and HIV-1 protease inhibitors.

R B Stricker, B Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9802307     DOI： 10.1016/S0140-6736(05)60792-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the Italian version of assessment of body change and distress questionnaire.

Authors:  G Guaraldi; G Orlando; R Murri; M Vandelli; M De Paola; B Beghetto; G Nardini; S Ciaffi; F Vichi; A W Wu
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

Review 2.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 3.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  High frequency of Fredrickson's phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus.

Authors:  Edilma M V Albuquerque; Eliana C de Faria; Helena C F Oliveira; Daniela O Magro; Lucia N Castilho
Journal:  BMC Infect Dis       Date:  2005-06-14       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.